178 related articles for article (PubMed ID: 33870649)
1. Translational Nanotherapeutics Reprograms Immune Microenvironment in Malignant Pleural Effusion of Lung Adenocarcinoma.
Song Z; Luo W; Zheng H; Zeng Y; Wang J; Chen T
Adv Healthc Mater; 2021 Jun; 10(12):e2100149. PubMed ID: 33870649
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
[TBL] [Abstract][Full Text] [Related]
3. The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
Wu MF; Lin CA; Yuan TH; Yeh HY; Su SF; Guo CL; Chang GC; Li KC; Ho CC; Chen HW
Cancer Immunol Immunother; 2021 May; 70(5):1435-1450. PubMed ID: 33175182
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y
Front Immunol; 2021; 12():760683. PubMed ID: 34966384
[TBL] [Abstract][Full Text] [Related]
5. CD39 identifies a specific CD8 + T cell population in lung adenocarcinoma-related metastatic pleural effusion.
Lv LL; Wang HB; Zhang YX; Zhai JW; Shen Y; Qu QX; Chen C
BMC Immunol; 2023 Dec; 24(1):53. PubMed ID: 38087217
[TBL] [Abstract][Full Text] [Related]
6. Th17/Treg imbalance in malignant pleural effusion.
Yang WB; Ye ZJ; Xiang F; Zhang JC; Zhou Q
J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):27-32. PubMed ID: 23392703
[TBL] [Abstract][Full Text] [Related]
7. TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating T
Yi FS; Zhang X; Zhai K; Huang ZY; Wu XZ; Wu MT; Shi XY; Pei XB; Dong SF; Wang W; Yang Y; Du J; Luo ZT; Shi HZ
J Immunol; 2020 Nov; 205(10):2926-2935. PubMed ID: 33046503
[TBL] [Abstract][Full Text] [Related]
8. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J
Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165
[TBL] [Abstract][Full Text] [Related]
9. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.
Liu Y; Wang L; Song Q; Ali M; Crowe WN; Kucera GL; Hawkins GA; Soker S; Thomas KW; Miller LD; Lu Y; Bellinger CR; Zhang W; Habib AA; Petty WJ; Zhao D
Nat Nanotechnol; 2022 Feb; 17(2):206-216. PubMed ID: 34916656
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion.
Shao MM; Pei XB; Chen QY; Wang F; Wang Z; Zhai K
Front Immunol; 2023; 14():1161375. PubMed ID: 37143656
[TBL] [Abstract][Full Text] [Related]
12. Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion.
Guo M; Wu F; Hu G; Chen L; Xu J; Xu P; Wang X; Li Y; Liu S; Zhang S; Huang Q; Fan J; Lv Z; Zhou M; Duan L; Liao T; Yang G; Tang K; Liu B; Liao X; Tao X; Jin Y
Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626714
[TBL] [Abstract][Full Text] [Related]
13. Activated naïve B cells promote development of malignant pleural effusion by differential regulation of T
Wu XZ; Shi XY; Zhai K; Yi FS; Wang Z; Wang W; Pei XB; Xu LL; Wang Z; Shi HZ
Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L443-L455. PubMed ID: 29847991
[TBL] [Abstract][Full Text] [Related]
14. Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.
Li L; Yang L; Wang L; Wang F; Zhang Z; Li J; Yue D; Chen X; Ping Y; Huang L; Zhang B; Zhang Y
Int J Cancer; 2016 Nov; 139(10):2261-9. PubMed ID: 27459735
[TBL] [Abstract][Full Text] [Related]
15. Helper T cells in malignant pleural effusion.
Yi FS; Zhai K; Shi HZ
Cancer Lett; 2021 Mar; 500():21-28. PubMed ID: 33309856
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion.
Tao H; Meng Q; Li M; Shi L; Tang J; Liu Z
Thorac Cancer; 2018 Feb; 9(2):298-304. PubMed ID: 29297985
[TBL] [Abstract][Full Text] [Related]
17. Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma.
Huang D; Zhuo J; Ye C; Su X; Chen Y; Li C; Lin L; Liu L; Zhao H; Luo T; Ren Q; Wu J; Cai S; Dong H
Thorac Cancer; 2023 Jul; 14(21):2045-2056. PubMed ID: 37309281
[TBL] [Abstract][Full Text] [Related]
18. Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion.
Ye ZJ; Zhou Q; Gu YY; Qin SM; Ma WL; Xin JB; Tao XN; Shi HZ
J Immunol; 2010 Nov; 185(10):6348-54. PubMed ID: 20952674
[TBL] [Abstract][Full Text] [Related]
19. Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion.
Niu Y; Zhou Q
Cell Mol Life Sci; 2022 Mar; 79(4):194. PubMed ID: 35298721
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients.
Zhang Z; Ji W; Huang J; Zhang Y; Zhou Y; Zhang J; Dong Y; Yuan T; Yang Q; Ding X; Tang L; Li H; Yin J; Wang Y; Ji T; Fei J; Zhang B; Chen P; Hu H
Clin Transl Med; 2022 Nov; 12(11):e1072. PubMed ID: 36305631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
